throbber
Trans-ungual Delivery of AR-12, a Novel Antifungal Drug
`
`
`
`
`
`A. S. Kushwaha 1, P. Sharma 1, C. Rappleye 2, A. Zukiwski 3, S. Proniuk 3, S. N. Murthy 1
`1 University of Mississippi, 2 Ohio State University, 3 Arno Therapeutics
`Purpose
`With the growing prevalence of onychomycosis, there is also growing need for more potent and safer drugs for improving the success
`rate of topical therapy of onychomycosis. The novel antifungal drug AR-12 was found to be highly potent against T.rubrum and
`T.tonsurans, the fungal organisms predominantly responsible for causing onychomycosis. The objective of this project was to
`investigate the inherent ability of AR-12 to penetrate into and across the human nail plate. The second objective was to explore
`suitable permeability enhancers to improve the trans-ungual delivery of AR-12.
`Methods
`In vitro permeation studies of AR-12 was performed across the human cadaver nail plates using Franz diffusion cells. Donor and
`receiver compartments were filled with 0.5 ml of 5% w/v alcoholic drug solution and 5 ml of ethanol and phosphate buffer saline
`mixture ( l: l) respectively. Samples (200 µI) from the receiver compartments were withdrawn at different time points and the amount
`drug was analyzed by HPLC. TranScreen-N method was followed to screen the potential permeability enhancers. Then, In vitro
`transport studies of AR-12 with leading enhancers were performed for 7 days.
`Results
`The amount of drug permeated across the nail plate after one week was 0.82±0.l l ng/cm2
`• The amount of drug retained in active
`diffusion area of the nail plate was ,...,().42±0.02 µg/mg .. TranScreen-N clearly showed that PEG-400 could be a potential enhancer of
`trans-ungual delivery of AR-12. Furthermore, in vitro permeation studies of AR-12 in presence of 100/o PEG-400 resulted in 6 folds
`more enhancement in trnas-ungual drug transport compared to control solution. The drug load in the nail plate was found to be 2 folds
`more in presence of l 0% PEG-400.
`Conclusion
`AR-12 is a promising novel antifungal for the treatment of onychomycosis. AR-12 has been found to penetrate across the nail plate in
`significant amounts which can be further improved with the use of appropriate permeation enhancer like PEG-400.
`
`A 1t EXHIBlT_j_
`Deponentf{l a ( #3-(cid:173)
`el'·-'·H~Rptr.-
`Dat
`£POBOOK.coM
`www.o
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1075 - Page 1 of 1

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket